RBFOX3 and chronic kidney disease: The results showed that the number of NeuN positive cells in the CA1 and CA3 regions of the hippocampus of CKD mice was significantly reduced, while doses of CLMD-M and CLMD-H could significantly reduce the number of neurons lost in the CA1 and CA3 regions of the hippocampus in CKD mice (Figure 4).